Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency.
Authors : Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J
Year : 2021
Journal : Radiother Oncol
Volume : 159
Pages : 106-111